Roles of plant-derived bioactive compounds and related microRNAs in cancer therapy.

Heng Zou, Yanli Li, Xiaomin Liu, Zong Wu, Jingjing Li, Zhongliang Ma

Journal: Phytotherapy research : PTR 2021;35(3):1176-1186

PMID: 33000538

Abstract

Plant-derived bioactive compounds, often called phytochemicals, are active substances extracted from different plants. These bioactive compounds can release therapeutic potential abilities via reducing antitumor drugs side effects or directly killing cancer cells, and others also can adjust cancer initiation and progression via regulating microRNAs (miRNAs) expression, and miRNA can regulate protein-coding expression by restraining translation or degrading target mRNA. A mass of research showed that plant-derived bioactive compounds including tanshinones, astragaloside IV, berberine, ginsenosides and matrine can inhibit tumor growth and metastasis by rescuing aberrant miRNAs expression, which has influence on tumor progression, microenvironment and drug resistance in multifarious cancers. This review aims to provide a novel understanding of plant-derived bioactive compounds targeting miRNAs and shed light on their future clinical applications.

© 2020 John Wiley & Sons Ltd.

Address: Lab for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai, China.; School of Pharmaceutical Engineering, Zhejiang Pharmaceutical College, Ningbo, China.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.